SEC Form 4 · accession 0001209191-18-058552
Azenta, Inc. · AZTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maurice H. Tenney
Officer — President-Brooks Life Sciences
Period of report
Nov 12, 2018
Accepted (ET)
Nov 14, 2018 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000933974
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 12, 2018 | S | 46,487 | $30.93 | D | 142,430 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 6, 2018 of 103,140 restricted stock units held by the reporting person.
- F2This represents the weighted average price for shares sold between November 7, 2018 and November 12, 2018 at a range between $28.00 and $32.35. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.